FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Boston, Massachusetts

Biotech startups that raised Series B in Boston, Massachusetts

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Boston, Massachusetts
One-time CSV
  • 40 funded companies, 36 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~boston-massachusetts.csv40 rows × 18 columns
CompanyCityLast roundAmountDate
Superluminal MedicinesBostonSeries B$65.5M2026-09-03
Precede BiosciencesBostonSeries B$63.5M2026-01-12
VideaHealthBostonSeries B$40.0M2025-01-28
GRO BiosciencesBostonSeries B$60.3M2024-07-19
Cardurion PharmaceuticalsBostonSeries B$260.0M2024-07-16
Elion TherapeuticsBostonSeries B$81.0M2024-06-17
SwareBostonSeries B$6.0M2024-06-06
DermBiontBostonSeries B$35.2M2023-10-19

8 rows of the CSV in 5 of its 18 columns.

40
Startups
$3.7B
Total raised
5
Funded in the last 12 months
$399.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

5 of 40
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005
VideaHealth VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. Biotech Series B $40.0M 2025-01-28 $66.5M Spark Capital, Zetta Venture Partners, Pillar VC +2 51 to 100 2018
Cardurion Pharmaceuticals Cardurion Pharmaceuticals develops cardiovascular therapeutics for heart failure and related diseases. Biotech Series B $260.0M 2024-07-16 $603.1M New Enterprise Associates, Google Ventures, Fidelity +1 11 to 50 2017
Asimov Asimov uses artificial intelligence to build tools for designing and manufacturing therapeutics. Artificial intelligence Series B $175.0M 2023-01-05 $205.0M Andreessen Horowitz, DCVC, Fidelity +2 101 to 250 2017

Table 1. Biotech startups that raised Series B in Boston, Massachusetts: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 40.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
2 Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005

Table 2. Biotech startups that raised Series B in Boston, Massachusetts: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Insight Partners Private equity firm New York, United States 2 5% 1 Superluminal Medicines
2 Fidelity Investment bank Boston, United States 2 5%
3 New Enterprise Associates Venture capital firm Menlo Park, United States 2 5%
4 RA Capital Management Startup incubator Boston, United States 1 2% 1 Superluminal Medicines
5 NVentures Corporate venture arm Santa Clara, United States 1 2% 1 Superluminal Medicines
6 Qatar Investment Authority Fund of funds Doha, Qatar 1 2% 1 Precede Biosciences
7 Lilly Asia Ventures Venture capital firm Shanghai, China 1 2% 1 Precede Biosciences
8 Bristol-Myers Squibb Venture capital firm New York, United States 1 2% 1 Precede Biosciences
9 5AM Ventures Venture capital firm Menlo Park, United States 1 2% 1 Precede Biosciences
10 Illumina Ventures Corporate venture arm Foster City, United States 1 2% 1 Precede Biosciences
11 Pillar VC Venture capital firm Boston, United States 1 2%
12 Innospark Ventures Venture capital firm Boston, United States 1 2%
13 Spark Capital Venture capital firm San Francisco, United States 1 2%
14 Zetta Venture Partners Venture capital firm San Francisco, United States 1 2%
15 MIT delta v Startup accelerator Cambridge, United States 1 2%

Table 3. Biotech startups that raised Series B in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 37 92% $3.5B
Software 7 18% $634.1M
Artificial intelligence 4 10% $483.5M
Hardware 2 5% $54.2M
Commerce 1 2% $55.0M

Table 4. Biotech startups that raised Series B in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 40 100% $50.0M

Table 5. Biotech startups that raised Series B in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 20% $135.0M
September 2026 1 20% $65.5M
January 2026 2 40% $139.5M
November 2025 1 20% $59.2M

Table 6. Biotech startups that raised Series B in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 10% $340.0M
2025 5 12% $286.2M
2024 6 15% $598.5M
2023 6 15% $433.2M
2022 4 10% $180.5M
2021 2 5% $80.0M

Table 7. Biotech startups that raised Series B in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 5 12%
2015 to 2019 17 42%
2010 to 2014 8 20%
Before 2010 10 25%

Table 8. Biotech startups that raised Series B in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 8 21%
11 to 50 17 45%
51 to 100 8 21%
101 to 250 4 11%
501 to 1,000 1 3%

Table 9. Biotech startups that raised Series B in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Boston, Massachusetts whose last round is Series B are on the list?
40, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 40 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Boston, Massachusetts: 40 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Boston

Other sectors that raised Series B in Boston

Cite: FundingWatcher, 40 biotech companies in Boston, Massachusetts whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/boston-massachusetts/